258 related articles for article (PubMed ID: 28157697)
1. TRIP13 impairs mitotic checkpoint surveillance and is associated with poor prognosis in multiple myeloma.
Tao Y; Yang G; Yang H; Song D; Hu L; Xie B; Wang H; Gao L; Gao M; Xu H; Xu Z; Wu X; Zhang Y; Zhu W; Zhan F; Shi J
Oncotarget; 2017 Apr; 8(16):26718-26731. PubMed ID: 28157697
[TBL] [Abstract][Full Text] [Related]
2. Mad2 Overexpression Uncovers a Critical Role for TRIP13 in Mitotic Exit.
Marks DH; Thomas R; Chin Y; Shah R; Khoo C; Benezra R
Cell Rep; 2017 May; 19(9):1832-1845. PubMed ID: 28564602
[TBL] [Abstract][Full Text] [Related]
3. Thyroid hormone receptor interactor 13 (TRIP13) overexpression associated with tumor progression and poor prognosis in lung adenocarcinoma.
Li W; Zhang G; Li X; Wang X; Li Q; Hong L; Shen Y; Zhao C; Gong X; Chen Y; Zhou J
Biochem Biophys Res Commun; 2018 May; 499(3):416-424. PubMed ID: 29567476
[TBL] [Abstract][Full Text] [Related]
4. TRIP13 Functions in the Establishment of the Spindle Assembly Checkpoint by Replenishing O-MAD2.
Ma HT; Poon RYC
Cell Rep; 2018 Feb; 22(6):1439-1450. PubMed ID: 29425500
[TBL] [Abstract][Full Text] [Related]
5. TRIP13 is a protein-remodeling AAA+ ATPase that catalyzes MAD2 conformation switching.
Ye Q; Rosenberg SC; Moeller A; Speir JA; Su TY; Corbett KD
Elife; 2015 Apr; 4():. PubMed ID: 25918846
[TBL] [Abstract][Full Text] [Related]
6. Mechanism for remodelling of the cell cycle checkpoint protein MAD2 by the ATPase TRIP13.
Alfieri C; Chang L; Barford D
Nature; 2018 Jul; 559(7713):274-278. PubMed ID: 29973720
[TBL] [Abstract][Full Text] [Related]
7. Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4.
Zhu MX; Wei CY; Zhang PF; Gao DM; Chen J; Zhao Y; Dong SS; Liu BB
J Exp Clin Cancer Res; 2019 Sep; 38(1):409. PubMed ID: 31533816
[TBL] [Abstract][Full Text] [Related]
8. Mode of interaction of TRIP13 AAA-ATPase with the Mad2-binding protein p31comet and with mitotic checkpoint complexes.
Miniowitz-Shemtov S; Eytan E; Kaisari S; Sitry-Shevah D; Hershko A
Proc Natl Acad Sci U S A; 2015 Sep; 112(37):11536-40. PubMed ID: 26324890
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic insight into TRIP13-catalyzed Mad2 structural transition and spindle checkpoint silencing.
Brulotte ML; Jeong BC; Li F; Li B; Yu EB; Wu Q; Brautigam CA; Yu H; Luo X
Nat Commun; 2017 Dec; 8(1):1956. PubMed ID: 29208896
[TBL] [Abstract][Full Text] [Related]
10. The conserved AAA-ATPase PCH-2
Défachelles L; Russo AE; Nelson CR; Bhalla N
Mol Biol Cell; 2020 Sep; 31(20):2219-2233. PubMed ID: 32697629
[TBL] [Abstract][Full Text] [Related]
11. Thyroid hormone receptor interacting protein 13 (TRIP13) AAA-ATPase is a novel mitotic checkpoint-silencing protein.
Wang K; Sturt-Gillespie B; Hittle JC; Macdonald D; Chan GK; Yen TJ; Liu ST
J Biol Chem; 2014 Aug; 289(34):23928-37. PubMed ID: 25012665
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of thyroid hormone receptor interactor 13 is associated with human hepatocellular carcinoma.
Ju L; Li X; Shao J; Lu R; Wang Y; Bian Z
Oncol Rep; 2018 Dec; 40(6):3794-3802. PubMed ID: 30542731
[TBL] [Abstract][Full Text] [Related]
13. A Small-Molecule Inhibitor Targeting TRIP13 Suppresses Multiple Myeloma Progression.
Wang Y; Huang J; Li B; Xue H; Tricot G; Hu L; Xu Z; Sun X; Chang S; Gao L; Tao Y; Xu H; Xie Y; Xiao W; Yu D; Kong Y; Chen G; Sun X; Lian F; Zhang N; Wu X; Mao Z; Zhan F; Zhu W; Shi J
Cancer Res; 2020 Feb; 80(3):536-548. PubMed ID: 31732653
[TBL] [Abstract][Full Text] [Related]
14. TRIP13 Regulates Both the Activation and Inactivation of the Spindle-Assembly Checkpoint.
Ma HT; Poon RYC
Cell Rep; 2016 Feb; 14(5):1086-1099. PubMed ID: 26832417
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of TRIP13 drives the tumorigenesis of bladder cancer in association with the EGFR signaling pathway.
Gao Y; Liu S; Guo Q; Zhang S; Zhao Y; Wang H; Li T; Gong Y; Wang Y; Zhang T; Dong Z; Bacich D; Chowdhury WH; Rodriguez R; Wang Z
Int J Biol Sci; 2019; 15(7):1488-1499. PubMed ID: 31337978
[TBL] [Abstract][Full Text] [Related]
16. Thyroid Receptor-Interacting Protein 13 is Correlated with Progression and Poor Prognosis in Bladder Cancer.
Niu L; Gao Z; Cui Y; Yang X; Li H
Med Sci Monit; 2019 Sep; 25():6660-6668. PubMed ID: 31486418
[TBL] [Abstract][Full Text] [Related]
17. The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13-MAPK-YWHAE signaling pathway.
Wang Y; Dong S; Hu K; Xu L; Feng Q; Li B; Wang G; Chen G; Zhang B; Jia X; Xu Z; Gao X; Zhang H; Xie Y; Lu M; Chang S; Song D; Wu X; Jia Q; Zhu H; Zhou J; Zhu W; Shi J
J Transl Med; 2023 Nov; 21(1):858. PubMed ID: 38012658
[TBL] [Abstract][Full Text] [Related]
18. TRIP13 promotes metastasis of colorectal cancer regardless of p53 and microsatellite instability status.
Agarwal S; Behring M; Kim HG; Chandrashekar DS; Chakravarthi BVSK; Gupta N; Bajpai P; Elkholy A; Al Diffalha S; Datta PK; Heslin MJ; Varambally S; Manne U
Mol Oncol; 2020 Dec; 14(12):3007-3029. PubMed ID: 33037736
[TBL] [Abstract][Full Text] [Related]
19. TRIP13 modulates protein deubiquitination and accelerates tumor development and progression of B cell malignancies.
Li C; Xia J; Franqui-Machin R; Chen F; He Y; Ashby TC; Teng F; Xu H; Liu D; Gai D; Johnson SK; van Rhee F; Janz S; Shaughnessy JD; Tricot G; Frech I; Zhan F
J Clin Invest; 2021 Jul; 131(14):. PubMed ID: 34061780
[TBL] [Abstract][Full Text] [Related]
20. Imbalance of the spindle-assembly checkpoint promotes spindle poison-mediated cytotoxicity with distinct kinetics.
Zeng X; Xu WK; Lok TM; Ma HT; Poon RYC
Cell Death Dis; 2019 Apr; 10(4):314. PubMed ID: 30952840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
